Abstract
A growing amount of evidence demonstrates that Endothelial Progenitor Cells (EPCs) are involved in adult neovasculogenesis and maintenance of vascular integrity. EPC decrease and dysfunction are related to atherosclerosis and cardiovascular disease (CVD), and it has been proposed that the level of circulating EPCs may be used as a surrogate index of cumulative cardiovascular risk. Moreover, many experimental approaches reveal that exogenous EPC injection stimulates blood flow recovery in critical limb and myocardial ischemia, providing a new therapeutic tool for CVD. Diabetes Mellitus is a clinical condition characterized by a high incidence of CVD and is indeed associated with alterations in EPC physiology. In this review we focus on the relationships between EPCs and vascular biology, with particular regard to Diabetes Mellitus and future therapeutical implications.
Keywords: endothelium, diabetes, angiogenesis
Current Diabetes Reviews
Title: Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
Volume: 1 Issue: 1
Author(s): Gian P. Fadini, Carlo Agostini and Angelo Avogaro
Affiliation:
Keywords: endothelium, diabetes, angiogenesis
Abstract: A growing amount of evidence demonstrates that Endothelial Progenitor Cells (EPCs) are involved in adult neovasculogenesis and maintenance of vascular integrity. EPC decrease and dysfunction are related to atherosclerosis and cardiovascular disease (CVD), and it has been proposed that the level of circulating EPCs may be used as a surrogate index of cumulative cardiovascular risk. Moreover, many experimental approaches reveal that exogenous EPC injection stimulates blood flow recovery in critical limb and myocardial ischemia, providing a new therapeutic tool for CVD. Diabetes Mellitus is a clinical condition characterized by a high incidence of CVD and is indeed associated with alterations in EPC physiology. In this review we focus on the relationships between EPCs and vascular biology, with particular regard to Diabetes Mellitus and future therapeutical implications.
Export Options
About this article
Cite this article as:
Fadini P. Gian, Agostini Carlo and Avogaro Angelo, Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives, Current Diabetes Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573399052952640
DOI https://dx.doi.org/10.2174/1573399052952640 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Irreversible Inhibition of Serine Proteases – Design and In Vivo Activity of Diaryl α-Aminophosphonate Derivatives
Current Medicinal Chemistry Ethyl Pyruvate: A Novel Treatment for Sepsis
Current Drug Targets Chymase Inhibitor As a Novel Therapeutic Strategy for Anti-Vascular Remodeling
Vascular Disease Prevention (Discontinued) Diagnosis and Prognosis of Fetal Cardiomyopathies: A Review
Current Pharmaceutical Design Associating Paracrine Communication to Regenerative Medicine: Search Strategies & Major Trends in Scientific and Patent Production
Recent Patents on Regenerative Medicine Non-Steroidal Anti-Inflammatory Drugs used as a Treatment Modality in Subarachnoid Hemorrhage
Current Drug Safety Therapeutic Use of Antioxidants in Sepsis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension
Current Vascular Pharmacology Bayes Syndrome and Imaging Techniques
Current Cardiology Reviews Microcirculation and NO-CO Studies of a Natural Extracellular Hemoglobin Developed for an Oxygen Therapeutic Carrier
Current Drug Discovery Technologies Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets Phosphoinositide 3-Kinase Gamma (PI3Kγ) Inhibitors for the Treatment of Inflammation and Autoimmune Disease
Recent Patents on Inflammation & Allergy Drug Discovery Off-Pump Coronary Artery Bypass Grafting; is it Still Relevant?
Current Cardiology Reviews Non-Cardiomyocytes in Heart Regeneration
Current Drug Targets Protective and Therapeutic Effects of Ghrelin in the Gut
Current Medicinal Chemistry Protease Inhibitors in the Clinic
Medicinal Chemistry Mechanisms, Prevention and Treatment of Distal Embolization
Current Pharmaceutical Design Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Current Cardiology Reviews Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases
Current Medicinal Chemistry